If TransEnterix stock is going to continue climbing, the company needs to show investors that the systems it's already placed aren't just going to sit idle. Predictable, recurring revenue from selling the consumable tools used during each procedure has made industry peer Intuitive Surgical a top stock.
Full Answer
How much is a share of transenterix worth?
Mar 30, 2022 · Earnings Growth. Earnings for TransEnterix are expected to grow in the coming year, from ($0.74) to ($0.52) per share. Price to Earnings Ratio vs. the Market. The P/E ratio of TransEnterix is -0.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Why was transenterix's stock flat on Wednesday?
Jan 20, 2021 · Many investors likely decided to lock in some gains and sell their shares at that point, which could be why TransEnterix's stock price ended the trading day essentially flat on Wednesday. This ...
Where can I buy transenterix trxC?
Mar 04, 2021 · Neutral. Negative. Very Negative. Source. Headline. Bariatric Surgical Devices Market size worth $ 2223.84 Million, Globally, by 2028 at 9.29% CAGR: Verified Market Research® - Yahoo Finance. finance.yahoo.com - April 14 at 9:56 AM. TransEnterix (NYSEAMERICAN:TRXC) Shares Up 1.2%. americanbankingnews.com - March 31 at 12:16 AM.
How did transenterix's David Milne make 209% profit?
Feb 10, 2021 · Shares of TransEnterix(NYSEMKT:TRXC) popped nearly 40% higher in trading today, perhaps in anticipation of the company’s Investor Day later this month. TRXC is a robotic surgery company ...
Is TransEnterix a good stock?
If the steep decline in revenue from instruments and accessories reported in the first nine months of 2020 continues, this stock will tank again. If instruments and accessories for Senhance Systems rebound and rise sharply, this could become a good stock to buy.Feb 27, 2021
What is the future of TRXC stock?
Given the current short-term trend, the stock is expected to fall -26.35% during the next 3 months and, with a 90% probability hold a price between $0.39 and $0.55 at the end of this 3-month period.
Is ascensus surgical a good stock to buy?
An attractively valued growth stock Considering analysts' revenue estimates for 2021 and 2022, the company should realistically grow its revenue well over 20% annually in the years ahead.Jan 18, 2022
What does TransEnterix Inc do?
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will change its corporate name to Asensus Surgical, Inc.Feb 23, 2021
Where can I buy TRXC stock?
Shares of TRXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
What is Tronclassic?
TRONCLASSIC (TRXC) is a cryptocurrency and operates on the Ethereum platform. TRONCLASSIC has a current supply of 1,000,000,000,000 with 0 in circulation.
Why did ascensus Surgical stock drop?
Asensus Surgical's addition to the Russell 2000 and Russell Microcap Indexes caused a spike in the company's stock price thanks to institutional investor action. After the initial period of increased visibility and demand, the share price has dropped 32% from its high in June.Jul 16, 2021
What happened to Asensus Surgical Inc?
On Feb. 23, the company announced that it was changing its name and ticker symbol. TransEnterix changed its official name to Asensus Surgical on its website and other such official communications. Additionally, on March 5, Asensus' ticker symbol changed from TRXC stock to ASXC stock.Mar 10, 2021
Why did TransEnterix change their name?
However, if you do a Google search for TRXC stock, you may come across some strange results. That's because Transenterix changed its name recently to Asensus Surgical (NYSEAMERICAN:ASXC), reflecting management's decision to focus on the company's Senhance Surgical System.Mar 23, 2021
What is the price of TRXC stock?
Key Turning Points52-Week High6.95Last Price4.08Fibonacci 50%3.62Fibonacci 38.2%2.8352-Week Low0.281 more row•Mar 4, 2021
Is Asensus surgical?
Asensus Surgical's technology platform, Senhance® Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning.Feb 23, 2021
How were TransEnterix's earnings last quarter?
TransEnterix, Inc. (NYSEAMERICAN:TRXC) issued its quarterly earnings results on Thursday, November, 5th. The medical instruments supplier reported...
Who are TransEnterix's key executives?
TransEnterix's management team includes the following people: Mr. Todd M. Pope , CEO, Pres & Director (Age 53) Mr. Joseph P. Slattery , Exec. V...
Who are some of TransEnterix's key competitors?
Some companies that are related to TransEnterix include Utah Medical Products (UTMD) , Accuray (ARAY) , Apollo Endosurgery (APEN) , Apyx Medica...
What other stocks do shareholders of TransEnterix own?
Based on aggregate information from My MarketBeat watchlists, some companies that other TransEnterix investors own include Oramed Pharmaceuticals...
What is TransEnterix's stock symbol?
TransEnterix trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "TRXC."
How do I buy shares of TransEnterix?
Shares of TRXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is TransEnterix's stock price today?
One share of TRXC stock can currently be purchased for approximately $0.63.
How much money does TransEnterix make?
TransEnterix has a market capitalization of $90.08 million and generates $8.53 million in revenue each year. The medical instruments supplier earns...
What is TransEnterix's official website?
The official website for TransEnterix is www.transenterix.com .
"Should I invest in TransEnterix stock?" "Should I trade "TRXC" stock today?"
According to our live Forecast System, TransEnterix Inc stock is a bad long-term (1-year) investme...
What is the TransEnterix stock price / share price today?
The TransEnterix stock price is 1.880 USD today.
Will TRXC stock price drop / fall?
Yes. The TransEnterix stock price may drop from 1.880 USD to 1.532 USD...
Will TRXC stock price grow / rise / go up?
No. See above .
Will TRXC stock price crash?
According to our analysis, this can happen.
Will TransEnterix stock price hit 10 USD price in a year?
Not within a year. See above .
Will TransEnterix stock price hit 20 USD price in a year?
Not within a year. See above .
Will TransEnterix stock price hit 50 USD price in a year?
Not within a year. See above .
What is Senhance used for?
Now what. The Senhance Surgical System can be used for multiple types of minimally-invasive laparoscopic surgeries in the chest, abdomen, and pelvis. Surgeons perform more than 6 million procedures in these areas in the U.S. and Europe every year.
What is ISU in surgery?
TransEnterix received approval in Europe on Tuesday for its Intelligent Surgical Unit (ISU), which adds machine-vision functions to the Senhance Surgical System. Senhance digital laparoscopic surgery programs in Europe will now have access to this innovative augmented-intelligence technology.
TransEnterix Media Sentiment
Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.
Media Coverage
We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.
TransEnterix (NYSEAMERICAN TRXC) News Headlines Today
Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm.
When was Transenterix last traded?
TransEnterix last traded above $3 in November 2019, more than 15 months ago. The run-up in its share price in 2021 has enabled the company to complete two bought deals totaling $94.25 million. The company intends to use the funds for general corporate purposes and research and development.
How much goodwill impairment is there in 2019?
In 2019, the company recorded a goodwill impairment charge of $79 million for lower sales and estimated cash flows. It also had a $7.9 million impairment charge to its in-process research and development (IPR&D). It’s important to note that page 31 of its 2019 10-K states, “Since inception, we have been unprofitable.